Screener
Arcus Biosciences RCUS Contract Assets
Contract Assets at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerAssetNetCurrent.
The source filing: Arcus Biosciences’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001724521-26-000044
FAQ
- What is Arcus Biosciences's contract assets?
- Arcus Biosciences (RCUS) reported contract assets of $36M in Q2 2026.
- How has Arcus Biosciences's contract assets changed year-over-year?
- Arcus Biosciences's contract assets increased by 140.0% year-over-year, from $15M to $36M.
- What is the long-term trend for Arcus Biosciences's contract assets?
- Over 5 years (2020 to 2025), Arcus Biosciences's contract assets has grown at a 60.0% compound annual growth rate (CAGR), from $1.05M to $11M.
- What does contract assets mean?
- Revenue recognized under ASC 606 where the right to payment is conditional on something other than the passage of time — work performed but not yet billable.
Ask your AI about Arcus Biosciences's contract assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude